Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE
Por um escritor misterioso
Descrição
Biologic therapies for chronic rhinosinusitis with nasal polyps: a new paradigm
Mepolizumab Reduces Systemic Corticosteroid Use in Chronic Rhinosinusitis With Nasal Polyps - ScienceDirect
Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study
Eosinophils & MOA NUCALA (mepolizumab) for CRSwNP
Frontiers Pathogenesis and treatment of chronic rhinosinusitis from the perspective of sinonasal epithelial dysfunction
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count - ScienceDirect
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis - Fokkens - 2023 - Allergy - Wiley Online Library
PDF] Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
